Showing 2637 results
- Media Release /Continuous Kesimpta® treatment for up to six years showed sustained efficacy in recently diagnosed (≤3 years) treatment-naïve people living with relapsing multiple sclerosis (RMS) in an analysis…
- Featured News /
Novartis announced the company’s financial results for the first quarter of 2024.
Pagination
- ‹ Previous page
- 1
- …
- 241
- 242
- 243
- 244
- 245
- 246
- 247
- …
- 264
- › Next page